SNDX Annual Net Income
-$209.36 M
-$60.02 M-40.19%
31 December 2023
Summary:
As of January 22, 2025, SNDX annual net profit is -$209.36 million, with the most recent change of -$60.02 million (-40.19%) on December 31, 2023. During the last 3 years, it has fallen by -$136.20 million (-186.18%). SNDX annual net income is now -939.93% below its all-time high of $24.93 million, reached on December 31, 2021.SNDX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SNDX Quarterly Net Income
-$84.13 M
-$16.06 M-23.60%
30 September 2024
Summary:
As of January 22, 2025, SNDX quarterly net profit is -$84.13 million, with the most recent change of -$16.06 million (-23.60%) on September 30, 2024. Over the past year, it has dropped by -$32.98 million (-64.48%). SNDX quarterly net income is now -187.45% below its all-time high of $96.20 million, reached on December 31, 2021.SNDX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SNDX TTM Net Income
-$297.06 M
-$32.98 M-12.49%
30 September 2024
Summary:
As of January 22, 2025, SNDX TTM net profit is -$297.06 million, with the most recent change of -$32.98 million (-12.49%) on September 30, 2024. Over the past year, it has dropped by -$120.98 million (-68.71%). SNDX TTM net income is now -1291.78% below its all-time high of $24.93 million, reached on December 31, 2021.SNDX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SNDX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.2% | -64.5% | -68.7% |
| 3 y3 years | -186.2% | -126.3% | -2019.0% |
| 5 y5 years | -183.1% | -126.3% | -2019.0% |
SNDX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -939.9% | at low | -187.4% | at low | -1291.8% | at low |
| 5 y | 5-year | -939.9% | at low | -187.4% | at low | -1291.8% | at low |
| alltime | all time | -939.9% | at low | -187.4% | at low | -1291.8% | at low |
Syndax Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$84.13 M(+23.6%) | -$297.06 M(+12.5%) |
| June 2024 | - | -$68.06 M(-6.0%) | -$264.08 M(+9.7%) |
| Mar 2024 | - | -$72.40 M(-0.1%) | -$240.63 M(+14.9%) |
| Dec 2023 | -$209.36 M(+40.2%) | -$72.47 M(+41.7%) | -$209.36 M(+18.9%) |
| Sept 2023 | - | -$51.15 M(+14.6%) | -$176.08 M(+9.8%) |
| June 2023 | - | -$44.62 M(+8.5%) | -$160.34 M(+4.6%) |
| Mar 2023 | - | -$41.13 M(+4.9%) | -$153.29 M(+2.6%) |
| Dec 2022 | -$149.34 M(-699.1%) | -$39.19 M(+10.7%) | -$149.34 M(+970.8%) |
| Sept 2022 | - | -$35.40 M(-5.8%) | -$13.95 M(-1804.9%) |
| June 2022 | - | -$37.57 M(+1.1%) | $818.00 K(-94.7%) |
| Mar 2022 | - | -$37.17 M(-138.6%) | $15.48 M(-37.9%) |
| Dec 2021 | $24.93 M(-134.1%) | $96.20 M(-566.1%) | $24.93 M(-127.2%) |
| Sept 2021 | - | -$20.64 M(-9.9%) | -$91.69 M(+0.2%) |
| June 2021 | - | -$22.91 M(-17.4%) | -$91.49 M(+6.8%) |
| Mar 2021 | - | -$27.72 M(+35.7%) | -$85.64 M(+17.1%) |
| Dec 2020 | -$73.16 M(+30.5%) | -$20.42 M(-0.1%) | -$73.16 M(+9.6%) |
| Sept 2020 | - | -$20.44 M(+19.8%) | -$66.73 M(+12.9%) |
| June 2020 | - | -$17.06 M(+12.0%) | -$59.13 M(+3.8%) |
| Mar 2020 | - | -$15.24 M(+8.8%) | -$56.98 M(+1.7%) |
| Dec 2019 | -$56.05 M(-24.2%) | -$14.00 M(+9.1%) | -$56.05 M(-7.9%) |
| Sept 2019 | - | -$12.83 M(-14.0%) | -$60.88 M(-6.9%) |
| June 2019 | - | -$14.92 M(+4.3%) | -$65.39 M(-5.0%) |
| Mar 2019 | - | -$14.30 M(-24.1%) | -$68.86 M(-6.9%) |
| Dec 2018 | -$73.96 M | -$18.84 M(+8.6%) | -$73.96 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$17.34 M(-5.7%) | -$74.23 M(+3.1%) |
| June 2018 | - | -$18.39 M(-5.2%) | -$71.98 M(+7.1%) |
| Mar 2018 | - | -$19.40 M(+1.5%) | -$67.23 M(+10.6%) |
| Dec 2017 | -$60.80 M(+36.7%) | -$19.10 M(+26.6%) | -$60.80 M(+15.8%) |
| Sept 2017 | - | -$15.09 M(+10.6%) | -$52.51 M(+0.2%) |
| June 2017 | - | -$13.64 M(+5.1%) | -$52.39 M(+11.2%) |
| Mar 2017 | - | -$12.97 M(+19.9%) | -$47.11 M(+5.9%) |
| Dec 2016 | -$44.47 M(+84.4%) | -$10.81 M(-27.8%) | -$44.47 M(+14.3%) |
| Sept 2016 | - | -$14.97 M(+79.1%) | -$38.92 M(+22.8%) |
| June 2016 | - | -$8.36 M(-19.1%) | -$31.68 M(+7.3%) |
| Mar 2016 | - | -$10.33 M(+96.3%) | -$29.54 M(+22.5%) |
| Dec 2015 | -$24.12 M(+21.6%) | -$5.26 M(-31.9%) | -$24.12 M(+7.7%) |
| Sept 2015 | - | -$7.73 M(+24.4%) | -$22.40 M(-0.2%) |
| June 2015 | - | -$6.21 M(+26.5%) | -$22.45 M(+8.3%) |
| Mar 2015 | - | -$4.91 M(+38.4%) | -$20.72 M(+4.5%) |
| Dec 2014 | -$19.83 M(+39.9%) | -$3.55 M(-54.3%) | -$19.83 M(-3.8%) |
| Sept 2014 | - | -$7.77 M(+73.2%) | -$20.61 M(+16.2%) |
| June 2014 | - | -$4.49 M(+11.6%) | -$17.73 M(+4.0%) |
| Mar 2014 | - | -$4.02 M(-7.1%) | -$17.05 M(+20.3%) |
| Dec 2013 | -$14.17 M(+42.2%) | -$4.33 M(-11.6%) | -$14.17 M(+44.0%) |
| Sept 2013 | - | -$4.89 M(+28.4%) | -$9.84 M(+98.9%) |
| June 2013 | - | -$3.81 M(+235.4%) | -$4.95 M(+335.4%) |
| Mar 2013 | - | -$1.14 M | -$1.14 M |
| Dec 2012 | -$9.96 M | - | - |
FAQ
- What is Syndax Pharmaceuticals annual net profit?
- What is the all time high annual net income for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual net income year-on-year change?
- What is Syndax Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly net income year-on-year change?
- What is Syndax Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals TTM net income year-on-year change?
What is Syndax Pharmaceuticals annual net profit?
The current annual net income of SNDX is -$209.36 M
What is the all time high annual net income for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual net profit is $24.93 M
What is Syndax Pharmaceuticals annual net income year-on-year change?
Over the past year, SNDX annual net profit has changed by -$60.02 M (-40.19%)
What is Syndax Pharmaceuticals quarterly net profit?
The current quarterly net income of SNDX is -$84.13 M
What is the all time high quarterly net income for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly net profit is $96.20 M
What is Syndax Pharmaceuticals quarterly net income year-on-year change?
Over the past year, SNDX quarterly net profit has changed by -$32.98 M (-64.48%)
What is Syndax Pharmaceuticals TTM net profit?
The current TTM net income of SNDX is -$297.06 M
What is the all time high TTM net income for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high TTM net profit is $24.93 M
What is Syndax Pharmaceuticals TTM net income year-on-year change?
Over the past year, SNDX TTM net profit has changed by -$120.98 M (-68.71%)